Literature DB >> 29653698

Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions.

Nicolas A Menzies1, Emory Wolf2, David Connors2, Meghan Bellerose2, Alyssa N Sbarra3, Ted Cohen3, Andrew N Hill4, Reza Yaesoubi3, Kara Galer2, Peter J White5, Ibrahim Abubakar6, Joshua A Salomon7.   

Abstract

Mathematical modelling is commonly used to evaluate infectious disease control policy and is influential in shaping policy and budgets. Mathematical models necessarily make assumptions about disease natural history and, if these assumptions are not valid, the results of these studies can be biased. We did a systematic review of published tuberculosis transmission models to assess the validity of assumptions about progression to active disease after initial infection (PROSPERO ID CRD42016030009). We searched PubMed, Web of Science, Embase, Biosis, and Cochrane Library, and included studies from the earliest available date (Jan 1, 1962) to Aug 31, 2017. We identified 312 studies that met inclusion criteria. Predicted tuberculosis incidence varied widely across studies for each risk factor investigated. For population groups with no individual risk factors, annual incidence varied by several orders of magnitude, and 20-year cumulative incidence ranged from close to 0% to 100%. A substantial proportion of modelled results were inconsistent with empirical evidence: for 10-year cumulative incidence, 40% of modelled results were more than double or less than half the empirical estimates. These results demonstrate substantial disagreement between modelling studies on a central feature of tuberculosis natural history. Greater attention to reproducing known features of epidemiology would strengthen future tuberculosis modelling studies, and readers of modelling studies are recommended to assess how well those studies demonstrate their validity.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 29653698      PMCID: PMC6070419          DOI: 10.1016/S1473-3099(18)30134-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  37 in total

1.  Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.

Authors:  S H FEREBEE; F W MOUNT
Journal:  Am Rev Respir Dis       Date:  1962-04

2.  Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

Authors:  C Dye; G P Garnett; K Sleeman; B G Williams
Journal:  Lancet       Date:  1998-12-12       Impact factor: 79.321

3.  Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam.

Authors:  Rosa Sloot; Maarten F Schim van der Loeff; Peter M Kouw; Martien W Borgdorff
Journal:  Am J Respir Crit Care Med       Date:  2014-11-01       Impact factor: 21.405

Review 4.  Controlled chemoprophylaxis trials in tuberculosis. A general review.

Authors:  S H Ferebee
Journal:  Bibl Tuberc       Date:  1970

5.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

Review 6.  The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

Authors:  B J Marais; R P Gie; H S Schaaf; A C Hesseling; C C Obihara; J J Starke; D A Enarson; P R Donald; N Beyers
Journal:  Int J Tuberc Lung Dis       Date:  2004-04       Impact factor: 2.373

7.  Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.

Authors:  Rein M G J Houben; Nicolas A Menzies; Tom Sumner; Grace H Huynh; Nimalan Arinaminpathy; Jeremy D Goldhaber-Fiebert; Hsien-Ho Lin; Chieh-Yin Wu; Sandip Mandal; Surabhi Pandey; Sze-Chuan Suen; Eran Bendavid; Andrew S Azman; David W Dowdy; Nicolas Bacaër; Allison S Rhines; Marcus W Feldman; Andreas Handel; Christopher C Whalen; Stewart T Chang; Bradley G Wagner; Philip A Eckhoff; James M Trauer; Justin T Denholm; Emma S McBryde; Ted Cohen; Joshua A Salomon; Carel Pretorius; Marek Lalli; Jeffrey W Eaton; Delia Boccia; Mehran Hosseini; Gabriela B Gomez; Suvanand Sahu; Colleen Daniels; Lucica Ditiu; Daniel P Chin; Lixia Wang; Vineet K Chadha; Kiran Rade; Puneet Dewan; Piotr Hippner; Salome Charalambous; Alison D Grant; Gavin Churchyard; Yogan Pillay; L David Mametja; Michael E Kimerling; Anna Vassall; Richard G White
Journal:  Lancet Glob Health       Date:  2016-10-06       Impact factor: 26.763

8.  The impact of realistic age structure in simple models of tuberculosis transmission.

Authors:  Ellen Brooks-Pollock; Ted Cohen; Megan Murray
Journal:  PLoS One       Date:  2010-01-07       Impact factor: 3.240

Review 9.  Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies.

Authors:  Christie Y Jeon; Megan B Murray
Journal:  PLoS Med       Date:  2008-07-15       Impact factor: 11.069

10.  Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.

Authors:  Robert W Aldridge; Dominik Zenner; Peter J White; Elizabeth J Williamson; Morris C Muzyamba; Poonam Dhavan; Davide Mosca; H Lucy Thomas; Maeve K Lalor; Ibrahim Abubakar; Andrew C Hayward
Journal:  Lancet       Date:  2016-10-11       Impact factor: 79.321

View more
  22 in total

Review 1.  Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.

Authors:  Julian S Peters; Jason R Andrews; Mark Hatherill; Sabine Hermans; Leonardo Martinez; Erwin Schurr; Yuri van der Heijden; Robin Wood; Roxana Rustomjee; Bavesh D Kana
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

2.  QuantiFERON-TB Gold Versus Tuberculin Screening and Care Retention Among Persons Experiencing Homelessness: Georgia, 2015-2017.

Authors:  Jeffrey M Collins; Udodirim Onwubiko; David P Holland
Journal:  Am J Public Health       Date:  2019-05-16       Impact factor: 9.308

Review 3.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

4.  Self-clearance of Mycobacterium tuberculosis infection: implications for lifetime risk and population at-risk of tuberculosis disease.

Authors:  Jon C Emery; Alexandra S Richards; Katie D Dale; C Finn McQuaid; Richard G White; Justin T Denholm; Rein M G J Houben
Journal:  Proc Biol Sci       Date:  2021-01-20       Impact factor: 5.349

5.  A case report of a tongue ulcer presented as the first sign of occult tuberculosis.

Authors:  Seo-Yeong Kim; Jin-Seok Byun; Jae-Kap Choi; Jae-Kwang Jung
Journal:  BMC Oral Health       Date:  2019-04-29       Impact factor: 2.757

6.  Comparison of the QuantiFERON-TB and tuberculin skin test for detection of latent tuberculosis infection in cancer patients in a developing country.

Authors:  Javier Leonardo Galindo; Adriana Catalina Galeano; David Alfonso Suarez-Zamora; Ana Milena Callejas; Mónica Patricia Caicedo-Verástegui; Darío Londoño; Luis Gerardo García-Herreros; Aylen Vanessa Ospina-Serrano; Alfredo Saavedra; Plutarco Garcíaherreros; Diana María Palacios; Margarita Baldión
Journal:  ERJ Open Res       Date:  2019-10-15

7.  Prevalence of oral lesions in tuberculosis: A cross sectional study.

Authors:  Purnendu Rout; Varsha Modipalle; Shruthi S Hedge; Nirav Patel; Sravani Uppala; Prajwal K Shetty
Journal:  J Family Med Prim Care       Date:  2019-12-10

8.  Comparative Modeling of Tuberculosis Epidemiology and Policy Outcomes in California.

Authors:  Nicolas A Menzies; Andrea Parriott; Sourya Shrestha; David W Dowdy; Ted Cohen; Joshua A Salomon; Suzanne M Marks; Andrew N Hill; Carla A Winston; Garrett R Asay; Pennan Barry; Adam Readhead; Jennifer Flood; James G Kahn; Priya B Shete
Journal:  Am J Respir Crit Care Med       Date:  2020-02-01       Impact factor: 21.405

9.  Improving the quality of modelling evidence used for tuberculosis policy evaluation.

Authors:  N A Menzies; C F McQuaid; G B Gomez; A Siroka; P Glaziou; K Floyd; R G White; R M G J Houben
Journal:  Int J Tuberc Lung Dis       Date:  2019-04-01       Impact factor: 2.373

10.  Cording Mycobacterium tuberculosis Bacilli Have a Key Role in the Progression towards Active Tuberculosis, Which is Stopped by Previous Immune Response.

Authors:  Lilibeth Arias; Paula Cardona; Martí Català; Víctor Campo-Pérez; Clara Prats; Cristina Vilaplana; Esther Julián; Pere-Joan Cardona
Journal:  Microorganisms       Date:  2020-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.